The AST handbook of transplant infections [[electronic resource] /] / edited by Deepali Kumar, Atul Humar ; associate editors, Emily Blumberg, Marian Michaels, Kieren Marr ; on behalf of the American Society of Transplantation Infectious Diseases Community of Practice |
Pubbl/distr/stampa | Chichester ; ; Hoboken, NJ, : Blackwell Pub., 2011 |
Descrizione fisica | xv, 171 p. : ill |
Disciplina | 616.9/8 |
Altri autori (Persone) |
KumarDeepali
HumarAtul |
Soggetto topico |
Communicable diseases
Transplantation of organs, tissues, etc - Complications |
ISBN |
1-4443-9794-X
1-4443-9792-3 1-283-40873-2 9786613408730 1-4443-9793-1 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-996226139603316 |
Chichester ; ; Hoboken, NJ, : Blackwell Pub., 2011 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. di Salerno | ||
|
The AST handbook of transplant infections / / edited by Deepali Kumar, Atul Humar ; associate editors, Emily Blumberg, Marian Michaels, Kieren Marr ; on behalf of the American Society of Transplantation Infectious Diseases Community of Practice |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Chichester ; ; Hoboken, NJ, : Blackwell Pub., 2011 |
Descrizione fisica | xv, 171 p. : ill |
Disciplina | 616.9/8 |
Altri autori (Persone) |
KumarDeepali
HumarAtul |
Soggetto topico |
Communicable diseases
Transplantation of organs, tissues, etc - Complications |
ISBN |
1-4443-9794-X
1-4443-9792-3 1-283-40873-2 9786613408730 1-4443-9793-1 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Intro -- The AST Handbook of Transplant Infections -- Contents -- List of Contributors -- Preface -- Acknowledgements -- Part I: General Issues and Infectious Syndromes -- 1 Timeline of Infections After Organ Transplant -- 2 Timeline of Infections After Hematopoietic Stem Cell Transplant -- 3 Immune Reconstitution After Myeloablative Stem Cell Transplant -- 4 Pre-transplant Infectious Disease Evaluation of the Organ Transplant Candidate -- 5 Pre-transplant Infectious Disease Evaluation of the Hematopoietic Stem Cell Transplant Candidate -- 6 Technical Complications after Organ Transplant and Associated Infections -- 7 Evaluation and Initial Treatment of Infectious Complications Among Organ Transplant Recipients -- 8 Management of Infections in Kidney Transplant Recipients -- 9 Management of Infections in Pancreas Transplant Recipients -- 10 Management of Infections in Liver Transplant Recipients -- 11 Management of Infections in Lung, Heart-Lung, and Heart Transplant Recipients -- 12 Management of Infections in Intestinal Transplant Recipients -- 13 Antimicrobial Management of Patients with Fever and Neutropenia Following Hematopoietic Stem Cell Transplantation -- Part II: Specific Pathogens -- 14 Cytomegalovirus -- 15 Epstein-Barr Virus and Post-transplant Lymphoproliferative Disorders -- 16 Management of herpes simplex virus -- 17 Management of Varicella Zoster Virus -- 18 Prevention and Treatment of Human Herpesvirus 6, 7 and 8 Infections in Transplant Recipients -- 19 BK Polyomavirus and Polyomavirus-associated Nephropathy -- 20 Respiratory Viruses -- 21 Human Papillomavirus -- 22 Hepatitis B -- 23 Hepatitis C Management in Transplant Candidates and Recipients -- 24 Management Algorithm for Transplantation in Patients with Human Immunodeficiency Virus -- 25 Management of Selected Fungal Infections After Transplantation.
26 Treatment of Nocardia Infections -- 27 Tuberculosis: Treatment and Prevention -- 28 Treatment of Non-tuberculous Mycobacterium Infections -- 29 Pneumocystis jiroveci Pneumonia: Prophylaxis and Therapy -- 30 Suggested Therapy of Clostridium difficile Colitis After Transplantation -- 31 Diagnosis and Treatment of Multidrug-Resistant Bacteria -- 32 Management of Selected Parasitic Infections After Transplant -- Part III: Donor Issues -- 33 Infectious Disease Evaluation of the Potential Organ Donor -- 34 Infectious Disease Evaluation of the Potential Hematopoietic Stem Cell Transplant Donor -- 35 Donor-derived Infections -- 36 Estimates of Window Period Length for Serology and Nucleic Acid Testing -- 37 Estimates of Residual Risk of HIV or HCV when using Selected Increased Risk Donor Categories -- 38 Management of Recipients of Hepatitis B Core Antibody-Positive Donor Organ -- 39 Donor Tuberculosis Issues: Potential Scenarios and Management -- Part IV: Prevention of Infections after Transplantation -- 40 Suggested Prophylaxis Regimens in Organ Transplant Recipients -- 41 Antimicrobial Prophylaxis Regimen for Allogeneic Hematopoietic Stem Cell Transplant Recipients -- 42 Antimicrobial Prophylaxis Regimen for Autologous Hematopoietic Stem Cell Transplant Recipients -- 43 Adult Vaccination Schedule After Solid Organ Transplant -- 44 Adult Vaccination Schedule After Allogeneic Stem Cell Transplant -- 45 Immunizations After Pediatric Solid Organ Transplant and Hematopoietic Stem Cell Transplant -- 46 Recommendations for Travel-related Vaccinations and Medications for Transplant Travelers -- 47 Safe Living Strategies for Transplant Patients -- Part V: Post-transplant Medications and Drug Interactions -- 48 Common Immunosuppressive Drugs, Mechanisms of Action, Side-effects, and Other Interactions. 49 Infectious Risks Associated with Anti-thymocyte Globulin (ATG, Thymoglobulin) -- 50 Infectious Risks Associated with Alemtuzumab (Campath) -- 51 Infectious Risks Associated with IL-2R Antagonist [Basiliximab (Simulect) and Daclizumab (Zenapax)] -- 52 Infectious Risks Associated With Rituximab (Rituxan) -- 53 Drug Interactions Between Antimicrobial Agents and Common Immunosuppressive Drugs Used in Transplantation -- 54 Antiviral Agents for Adult Transplant Recipients -- 55 Antifungal Agents in Adult Transplant Recipients -- 56 Antiviral Agents for Pediatric Transplant Recipients -- 57 Antifungal Agents for Pediatric Transplant Recipients -- Index -- A -- B -- C -- D -- E -- F -- G -- H -- I -- L -- M -- N -- O -- P -- Q -- R -- S -- T -- U -- V -- W -- Y -- Z. |
Altri titoli varianti | Handbook of transplant infections |
Record Nr. | UNINA-9910208840803321 |
Chichester ; ; Hoboken, NJ, : Blackwell Pub., 2011 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Emerging transplant infections : clinical challenges and implications / / Michele I. Morris, Camille Nelson Kotton and Cameron R. Wolfe (editors) |
Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
Descrizione fisica | 1 online resource (1737 pages) |
Disciplina | 617.954 |
Soggetto topico |
Transplantation of organs, tissues, etc - Complications
Transplantation immunology Infection Transplantation Immunology Infections Trasplantament d'òrgans Infeccions quirúrgiques Immunologia de la trasplantació |
Soggetto genere / forma | Llibres electrònics |
ISBN | 3-030-25869-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Intro -- Preface -- Contents -- About the Editors -- Contributors -- Part I: General Introduction -- 1 Impact of Infection on Transplant Outcomes: Transplant Infectious Disease Expertise as an Essential Component of Transplant ... -- Introduction -- The Essential Role of Infectious Disease Specialists in the Care of Transplant Patients -- Conclusion -- References -- 2 Introduction to Immunosuppression, Tolerance, and Infection Risk -- Introduction -- T-Cell, B-Cells, and the Innate Immune System Involvement in Rejection -- Other Elements of the Immune System Involved in Transplantation -- Therapeutics Impacting Immunosuppression -- Calcineurin Inhibitors -- Antiproliferative Agents -- mTOR Inhibitors -- Corticosteroids -- Co-stimulation Blockade -- Induction Therapies -- Anti-CD25 Monoclonal Antibodies -- Anti-CD52 Monoclonal Antibodies -- Polyclonal Antibodies -- Conclusion -- Key Points -- References -- 3 Changing Definition of Immunosuppression: Targeted Therapies and Resulting Emerging Infections and Their Prevention -- Introduction -- Belatacept -- Key Findings and Suggestions -- Basiliximab -- Key Findings and Suggestions -- Rituximab and Obinutuzumab -- Key Findings and Suggestions -- Alemtuzumab -- Key Findings and Suggestions -- Eculizumab -- Key Findings and Suggestions -- Ruxolitinib -- Key Findings and Suggestions -- Ibrutinib -- Key Findings and Suggestions -- Bortezomib -- Key Findings and Suggestions -- Brentuximab -- Key Findings and Suggestions -- Conclusions -- References -- 4 Stem Cell Transplantation: Infection Risk by Transplant Type and Emerging Trends in Infection Management -- Introduction -- Risk of Infection Post-HSCT -- General Immune Reconstitution After Hematopoietic Stem Cell Transplantation -- Aplastic Period -- NK Cells and T-Cells -- B-Cells and Immunoglobulins -- Graft-Versus-Host Disease.
Special Donor Populations -- Umbilical Cord Blood Transplantation -- Haploidentical Transplantation -- Pre-HSCT Recipient Infectious Disease Evaluation -- Prophylaxis and Management of Infection Post-HSCT -- Bacterial Infections -- Bloodstream Infections -- Diagnosis -- Management -- Gram-Positive Bacterial Infections -- Multidrug-Resistant Gram-Negative Bacterial Infections -- Bacterial Pneumonia -- Clostridioides Difficile -- Diagnosis -- Management -- Recurrent CDI -- Secondary Prophylaxis -- Fungal Infections -- Yeasts -- Disease Epidemiology -- Candida auris -- Diagnosis -- Blood Cultures -- Fungal Antigen Testing: Serum 1,3-Beta-D-Glucan -- Nanodiagnostics -- Candida auris-Specific Diagnostics -- Management -- Candida Species -- Candida auris -- Cryptococcus -- Molds -- Disease Epidemiology -- Clinical Impact -- Diagnosis -- Culture -- Galactomannan -- Aspergillus PCR -- Radiographic Studies -- Fungal Metabolite Testing -- Management -- Prophylaxis -- Treatment -- Pneumocystis Jiroveci -- Viral Infections -- Herpes Simplex Virus -- Varicella Zoster -- Cytomegalovirus -- Diagnosis -- Preemptive Management -- Prophylaxis: Shift in Management -- Drug-Resistant CMV Infection -- Epstein-Barr Virus -- Adenovirus -- BK Virus -- Parasitic Infections -- Toxoplasmosis -- Strongyloides -- Post-HSCT Vaccinations -- Conclusions -- Key Points -- Cross-References -- References -- 5 Evolving Epidemiology of Transplant Infections: Impact of Population Shifts and Climate Change -- Introduction -- Migration and Population Shift -- Modern Patterns of Human Migration and Infection -- Shifting Populations and the Changing Epidemiology of Infectious Diseases -- Preventative Strategies and Global Demographic Changes -- Climate Change and Infectious Diseases -- Climate Change and Parasitic Infections -- Climate Change and Vector-Borne Infections. Climate Change and Fungal Infections -- Climate Change and Bacterial Infections -- Conclusion -- Key Points -- References -- 6 Hospital Epidemiology and Infection Control in the Transplant Center -- Introduction -- Hand Hygiene -- Central Line-Associated Bloodstream Infections -- Catheter-Associated Urinary Tract Infections -- Clostridioides difficile -- Surgical Site Infections -- Preventing Infections Associated with the Healthcare Environment -- Environmental Mold -- Waterborne Pathogens -- Colonization with Multidrug-Resistant Organisms -- Respiratory Viruses -- Influenza -- Respiratory Syncytial Virus -- Adenovirus -- Other Respiratory Viruses -- Varicella-Zoster Virus -- Measles -- Healthcare Personnel Vaccination -- Conclusion -- Key Points -- Cross-References -- References -- 7 Antimicrobial Stewardship for Transplant Candidates and Recipients -- Introduction -- Implementing Antimicrobial Stewardship in Transplant Patients -- Formulary Management -- Pre-prescription Authorization and Post-prescriptive Review -- Antimicrobial Agent Selection -- Antibiotic Allergy Assessment -- Dose Optimization and Drug Interactions -- Intravenous-to-Oral Conversion -- Clinical Pathways and Guideline Development -- Diagnostic Test Stewardship -- Syndrome- and Drug-Specific Targets -- Antibiotic Stewardship -- Febrile Neutropenia -- Asymptomatic Bacteriuria in Organ Transplant Recipients -- Antiviral Stewardship -- Aerosolized Ribavirin for Management of RSV -- Cytomegalovirus (CMV) -- Antifungal Stewardship -- Antimicrobial Stewardship Program Metrics -- Conclusion -- Key Points -- References -- 8 Antimicrobial Prophylaxis in the Age of Emerging Transplant Infections -- Introduction -- Perioperative Antibacterial Prophylaxis in Solid Organ Transplantation -- Antibiotic Prophylaxis After Transplantation -- Antifungal Prophylaxis After Transplantation. Mycobacterial Prophylaxis After Transplantation -- Influenza Prophylaxis After Transplantation -- Herpes Simplex Virus and Varicella Zoster Virus Prophylaxis After Transplantation -- Cytomegalovirus Prophylaxis After Transplantation -- BK Polyomavirus Prophylaxis After Transplantation -- Parasitic Prophylaxis in Transplantation -- Conclusion -- Key Points -- References -- 9 Pretransplant Screening for Infection Exposure: Approach to the Patients with Epidemiologic and Geographic Risk Factors -- Introduction -- Bacterial Infections -- Bacterial Pathogens of Special Interest -- Mycobacterial Infections -- Tuberculosis -- Nontuberculous Mycobacteria -- M. abscessus -- Non-M. abscessus Non-M. tuberculosis Mycobacterial Infections -- Fungi -- Endemic Fungal Infections -- Histoplasmosis -- Blastomycosis -- Paracoccidioidomycosis -- Coccidioidomycosis -- Cryptococcosis -- Aspergillus and Other Molds -- Parasitic Infections -- Chagas Disease -- Schistosomiasis -- Strongyloidiasis -- Leishmaniasis -- Malaria -- Toxoplasmosis -- Viral Infections in the Transplant Candidate -- Blood-borne Pathogens -- Endemic Human Herpes Viruses -- Viral Infections with Geographic Associations -- Human Herpesvirus-8 (HHV-8) -- HTLV-1 -- Flaviviruses (Arboviruses) -- West Nile Virus (WNV) -- Zika, Chikungunya, and Dengue Viruses -- Conclusion -- KeyPoints -- References -- 10 Transplant Tourism and the Traveling Transplant Recipient: Infection Mitigation and Treatment Strategies -- Introduction -- Part 1: Transplant Tourism -- Introduction -- Transplant Tourism and Infectious Complications -- Conclusion -- Key Points -- Part 2: The Traveling Transplant Recipient -- Introduction -- Risk of Infection While Abroad -- Viral Infections -- Respiratory Viral Infections -- Influenza -- Measles -- Middle Eastern Respiratory Syndrome -- Gastrointestinal Viral Infections -- Norovirus. Hepatitis A -- Hepatitis B -- Hepatitis E -- Polio -- Vector-Borne Viral Infections -- Yellow Fever -- Japanese Encephalitis -- Dengue, Chikungunya, and Zika -- Rabies -- Bacterial Infections -- Salmonella enterica Serovar Typhi -- Vibrio cholerae -- Enterotoxigenic Escherichia coli (ETEC) -- Neisseria meningitidis -- Streptococcus pneumoniae -- Clostridium tetani -- Corynebacterium diphtheriae -- Bordetella pertussis -- Mycobacterial Infections -- Mycobacterium tuberculosis -- Fungal Infections -- Parasitic Infections -- Vector-Borne Parasite Infections -- Plasmodium Species -- Leishmania Species -- Trypanosoma Species -- Babesia Species -- Environmentally Transmitted Parasite Infections -- Strongyloides stercoralis -- Schistosoma Species -- Ingested Parasitic Infections -- Pre-departure Infectious Disease Evaluation and Recommendations -- Vaccine Recommendations -- Risk Reduction of Non-vaccine-Preventable Infections -- Prevention of Food-Borne Illnesses and Diarrhea -- Respiratory Infections -- Insect Protection -- Environmental Exposures -- Blood-Borne Pathogens -- Sexually Transmitted Infections (STI) -- Post-travel Evaluation -- Conclusion -- Key Points -- References -- 11 Preventative Health in Solid Organ Transplant: Safe Living Post-transplant -- Introduction -- Pre-transplant Evaluation -- Vaccination -- Everyday Living Strategies -- Activities of Leisure -- Sexual Health -- Food and Water Safety -- Animal and Insect Precautions -- Travel Advice -- Conclusion -- Key Points -- References -- 12 Vaccination Strategies in Solid Organ and Stem Cell Transplant -- Introduction to Vaccination in Transplant Recipients -- Specific Vaccine Recommendations -- Vaccination Against Influenza -- Vaccination Against Pneumococcal Disease -- Vaccination Against Meningococcal Disease -- Vaccination Against Hepatitis B Virus. Vaccination Against Hepatitis A Virus. |
Record Nr. | UNINA-9910485605403321 |
Cham, Switzerland : , : Springer, , [2021] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Transplant infectious disease |
Pubbl/distr/stampa | [Copenhagen], : Munksgaard International Publishers, ©1999- |
Disciplina | 617.95 |
Soggetto topico |
Transplantation of organs, tissues, etc - Complications
Communicable diseases Infection Transplantation Communicable Diseases Infections Infection Control Transplants Complications médicales Greffe (Chirurgie) |
Soggetto genere / forma |
Fulltext
Internet Resource Periodical Periodicals. Périodique électronique (Descripteur de forme) Ressource Internet (Descripteur de forme) |
ISSN | 1399-3062 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Altri titoli varianti | Transplant infect dis |
Record Nr. | UNISA-996217652903316 |
[Copenhagen], : Munksgaard International Publishers, ©1999- | ||
Materiale a stampa | ||
Lo trovi qui: Univ. di Salerno | ||
|
Transplant infectious disease |
Pubbl/distr/stampa | [Copenhagen], : Munksgaard International Publishers, ©1999- |
Disciplina | 617.95 |
Soggetto topico |
Transplantation of organs, tissues, etc - Complications
Communicable diseases Infection Transplantation Communicable Diseases Infections Infection Control Transplants Complications médicales Greffe (Chirurgie) |
Soggetto genere / forma |
Fulltext
Internet Resource Periodical Periodicals. Périodique électronique (Descripteur de forme) Ressource Internet (Descripteur de forme) |
ISSN | 1399-3062 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Altri titoli varianti | Transplant infect dis |
Record Nr. | UNINA-9910138974703321 |
[Copenhagen], : Munksgaard International Publishers, ©1999- | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|